Prevalence and Characteristics of Cancer Patients with COVID-19: A Meta-analysis Study (PRISMA Flowchart and PRISMA Checklist)

"Prevalence and Characteristics of Cancer Patients with COVID-19" is a meta-analysis study that uses PRISMA guidelines with PRISMA flow diagrams and PRISMA checklists in making this study. The flow diagram depicts the flow of information through the different phases of this systematic revi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Sitanggang, Johan Samuel, Siregar, Kamal Basri, Sitanggang, Henry Hamonangan, Vinolina, Noverita Sprinse
Format:	Dataset
Sprache:	eng
Schlagworte:	Epidemiology FOS: Clinical medicine FOS: Health sciences Medical Virology Oncology and Carcinogenesis not elsewhere classified
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	Sitanggang, Johan Samuel Siregar, Kamal Basri Sitanggang, Henry Hamonangan Vinolina, Noverita Sprinse
description	"Prevalence and Characteristics of Cancer Patients with COVID-19" is a meta-analysis study that uses PRISMA guidelines with PRISMA flow diagrams and PRISMA checklists in making this study. The flow diagram depicts the flow of information through the different phases of this systematic review and meta-analysis. It maps out the number of records identified, included and excluded, and the reasons for exclusions. Meanwhile, the PRISMA checklists comprise a 27-item checklist addressing the introduction, methods, results and discussion sections of this systematic review and meta-analysis. Data from inclusion studies were analyzed using Review Manager 5.4. The results of this study found that the prevalence of cancer in COVID-19 patients was 4.63% (95% CI, 3.78-5.49%) worldwide.
doi_str_mv	10.6084/m9.figshare.16590044
format	Dataset
fullrecord	<record><control><sourceid>datacite_PQ8</sourceid><recordid>TN_cdi_datacite_primary_10_6084_m9_figshare_16590044</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_6084_m9_figshare_16590044</sourcerecordid><originalsourceid>FETCH-LOGICAL-d914-36f17847c99d0e39de46a75a6e188d0455afc8014775ebb8d7ebf43dcdbafd943</originalsourceid><addsrcrecordid>eNo1kD1PwzAURb0woMI_YPAIQ4KtOB9miwKFSK0a0Yo1erGfiUWSothQZeG3N0A7Xele6VzpEHLDWZiwTNz3MjT23bUwYsiTWDImxCX5qUb8hg4HhRQGTYt5B-VxtM5b5eje0ALmcaQVeIuDd_RgfUuLzVv5GHD5QHO6Rg8BDNBNzjq69V96orfVa7ld53TZ7Q9qZvo_-qksWlQf3fxwd0UuDHQOr0-5ILvl0654CVab57LIV4GWXARRYniaiVRJqRlGUqNIII0hQZ5lmok4BqMyxkWaxtg0mU6xMSLSSjdgtBTRgoh_rAYPynqsP0fbwzjVnNW_dupe1mc79dlOdASr6GC9</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>dataset</recordtype></control><display><type>dataset</type><title>Prevalence and Characteristics of Cancer Patients with COVID-19: A Meta-analysis Study (PRISMA Flowchart and PRISMA Checklist)</title><source>DataCite</source><creator>Sitanggang, Johan Samuel ; Siregar, Kamal Basri ; Sitanggang, Henry Hamonangan ; Vinolina, Noverita Sprinse</creator><creatorcontrib>Sitanggang, Johan Samuel ; Siregar, Kamal Basri ; Sitanggang, Henry Hamonangan ; Vinolina, Noverita Sprinse</creatorcontrib><description>"Prevalence and Characteristics of Cancer Patients with COVID-19" is a meta-analysis study that uses PRISMA guidelines with PRISMA flow diagrams and PRISMA checklists in making this study. The flow diagram depicts the flow of information through the different phases of this systematic review and meta-analysis. It maps out the number of records identified, included and excluded, and the reasons for exclusions. Meanwhile, the PRISMA checklists comprise a 27-item checklist addressing the introduction, methods, results and discussion sections of this systematic review and meta-analysis. Data from inclusion studies were analyzed using Review Manager 5.4. The results of this study found that the prevalence of cancer in COVID-19 patients was 4.63% (95% CI, 3.78-5.49%) worldwide.</description><identifier>DOI: 10.6084/m9.figshare.16590044</identifier><language>eng</language><publisher>figshare</publisher><subject>Epidemiology ; FOS: Clinical medicine ; FOS: Health sciences ; Medical Virology ; Oncology and Carcinogenesis not elsewhere classified</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>780,1894</link.rule.ids><linktorsrc>$$Uhttps://commons.datacite.org/doi.org/10.6084/m9.figshare.16590044$$EView_record_in_DataCite.org$$FView_record_in_$$GDataCite.org$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Sitanggang, Johan Samuel</creatorcontrib><creatorcontrib>Siregar, Kamal Basri</creatorcontrib><creatorcontrib>Sitanggang, Henry Hamonangan</creatorcontrib><creatorcontrib>Vinolina, Noverita Sprinse</creatorcontrib><title>Prevalence and Characteristics of Cancer Patients with COVID-19: A Meta-analysis Study (PRISMA Flowchart and PRISMA Checklist)</title><description>"Prevalence and Characteristics of Cancer Patients with COVID-19" is a meta-analysis study that uses PRISMA guidelines with PRISMA flow diagrams and PRISMA checklists in making this study. The flow diagram depicts the flow of information through the different phases of this systematic review and meta-analysis. It maps out the number of records identified, included and excluded, and the reasons for exclusions. Meanwhile, the PRISMA checklists comprise a 27-item checklist addressing the introduction, methods, results and discussion sections of this systematic review and meta-analysis. Data from inclusion studies were analyzed using Review Manager 5.4. The results of this study found that the prevalence of cancer in COVID-19 patients was 4.63% (95% CI, 3.78-5.49%) worldwide.</description><subject>Epidemiology</subject><subject>FOS: Clinical medicine</subject><subject>FOS: Health sciences</subject><subject>Medical Virology</subject><subject>Oncology and Carcinogenesis not elsewhere classified</subject><fulltext>true</fulltext><rsrctype>dataset</rsrctype><creationdate>2021</creationdate><recordtype>dataset</recordtype><sourceid>PQ8</sourceid><recordid>eNo1kD1PwzAURb0woMI_YPAIQ4KtOB9miwKFSK0a0Yo1erGfiUWSothQZeG3N0A7Xele6VzpEHLDWZiwTNz3MjT23bUwYsiTWDImxCX5qUb8hg4HhRQGTYt5B-VxtM5b5eje0ALmcaQVeIuDd_RgfUuLzVv5GHD5QHO6Rg8BDNBNzjq69V96orfVa7ld53TZ7Q9qZvo_-qksWlQf3fxwd0UuDHQOr0-5ILvl0654CVab57LIV4GWXARRYniaiVRJqRlGUqNIII0hQZ5lmok4BqMyxkWaxtg0mU6xMSLSSjdgtBTRgoh_rAYPynqsP0fbwzjVnNW_dupe1mc79dlOdASr6GC9</recordid><startdate>20210908</startdate><enddate>20210908</enddate><creator>Sitanggang, Johan Samuel</creator><creator>Siregar, Kamal Basri</creator><creator>Sitanggang, Henry Hamonangan</creator><creator>Vinolina, Noverita Sprinse</creator><general>figshare</general><scope>DYCCY</scope><scope>PQ8</scope></search><sort><creationdate>20210908</creationdate><title>Prevalence and Characteristics of Cancer Patients with COVID-19: A Meta-analysis Study (PRISMA Flowchart and PRISMA Checklist)</title><author>Sitanggang, Johan Samuel ; Siregar, Kamal Basri ; Sitanggang, Henry Hamonangan ; Vinolina, Noverita Sprinse</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-d914-36f17847c99d0e39de46a75a6e188d0455afc8014775ebb8d7ebf43dcdbafd943</frbrgroupid><rsrctype>datasets</rsrctype><prefilter>datasets</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Epidemiology</topic><topic>FOS: Clinical medicine</topic><topic>FOS: Health sciences</topic><topic>Medical Virology</topic><topic>Oncology and Carcinogenesis not elsewhere classified</topic><toplevel>online_resources</toplevel><creatorcontrib>Sitanggang, Johan Samuel</creatorcontrib><creatorcontrib>Siregar, Kamal Basri</creatorcontrib><creatorcontrib>Sitanggang, Henry Hamonangan</creatorcontrib><creatorcontrib>Vinolina, Noverita Sprinse</creatorcontrib><collection>DataCite (Open Access)</collection><collection>DataCite</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Sitanggang, Johan Samuel</au><au>Siregar, Kamal Basri</au><au>Sitanggang, Henry Hamonangan</au><au>Vinolina, Noverita Sprinse</au><format>book</format><genre>unknown</genre><ristype>DATA</ristype><title>Prevalence and Characteristics of Cancer Patients with COVID-19: A Meta-analysis Study (PRISMA Flowchart and PRISMA Checklist)</title><date>2021-09-08</date><risdate>2021</risdate><abstract>"Prevalence and Characteristics of Cancer Patients with COVID-19" is a meta-analysis study that uses PRISMA guidelines with PRISMA flow diagrams and PRISMA checklists in making this study. The flow diagram depicts the flow of information through the different phases of this systematic review and meta-analysis. It maps out the number of records identified, included and excluded, and the reasons for exclusions. Meanwhile, the PRISMA checklists comprise a 27-item checklist addressing the introduction, methods, results and discussion sections of this systematic review and meta-analysis. Data from inclusion studies were analyzed using Review Manager 5.4. The results of this study found that the prevalence of cancer in COVID-19 patients was 4.63% (95% CI, 3.78-5.49%) worldwide.</abstract><pub>figshare</pub><doi>10.6084/m9.figshare.16590044</doi><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier	DOI: 10.6084/m9.figshare.16590044
ispartof
issn
language	eng
recordid	cdi_datacite_primary_10_6084_m9_figshare_16590044
source	DataCite
subjects	Epidemiology FOS: Clinical medicine FOS: Health sciences Medical Virology Oncology and Carcinogenesis not elsewhere classified
title	Prevalence and Characteristics of Cancer Patients with COVID-19: A Meta-analysis Study (PRISMA Flowchart and PRISMA Checklist)
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T22%3A15%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-datacite_PQ8&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.au=Sitanggang,%20Johan%20Samuel&rft.date=2021-09-08&rft_id=info:doi/10.6084/m9.figshare.16590044&rft_dat=%3Cdatacite_PQ8%3E10_6084_m9_figshare_16590044%3C/datacite_PQ8%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true